TNFRSF11B and prostate carcinoma: Both in vitro and in vivo studies conducted by Ye et al. also found that the release of miR-141-3p from prostate cancer cells was transferred to osteoblasts followed by increased expression of OPG via activation of p38 mitogen-activated protein kinase (MAPK) signaling.